Aislyn Boran

Senior Director, Translational Strategy

Daiichi Sankyo

Alain Beck

Senior Director, Biologics Chemistry, Manufacturing & Controls Developability

Pierre Fabre

Alex Robertson

Executive Director, CMC Project Management

AstraZeneca

Alexander Bijman

Director, Large Molecule External Manufacturing Technical Operations

MSD

Ali Salanti

Chief Executive Officer

VAR2 Pharmaceuticals

Alireza Tafazzol

Senior Scientist II, Oncology Bioinformatics

AbbVie

Andras Strassz

Chief Medical Officer

Heidelberg Pharma

Andrea Galbiati

Group Leader

Philochem

Andreas Pahl

Chief Executive Officer

Heidelberg Pharma

Arun Alphonse Ignatius

Director

MacroGenics

Benjamin Thomas

Senior Vice President, External Innovation

Oxford BioTherapeutics

Callum Angus

Senior Market Analyst

Hanson Wade Intelligence

Christian Marsolais

Senior Vice President & Chief Medical Officer

Theratechnologies

Colm Reddington

Senior Director, Global Regulatory CMC

AstraZeneca

Daisy Sun

Principal Scientist, Cell-Based Science

MSD

David Battersby

Team Leader, Associate Fellow

GSK

David Bramhill

President & Founder

Bramhill Biological Consulting

David Garcia Illescas

Medical Oncologist, Gynaecological Cancer Programme

University Hospital Vall d’Hebron

David Huang

Head, Medicinal Chemistry

OBI Pharma

Dhiraj Gambhire

Global Clinical Lead, Enhertu, Executive Medical Director

Daiichi Sankyo

Dongzhou Jeffrey Liu

Chief Scientific Officer

Huadong Medicine

Elizabeth Love

Scientific Leader, ADC Platform

GSK

Federico Riccardi Sirtori

Director & Head, NBE-DMPK Innovative Bioanalytics

Merck KGaA

Francois D’Hooge

Senior Manager, CMC Management

Daiichi Sankyo

Garrett Cornelison

Senior Principal Scientist

Pfizer

Gavin Bennet

Senior Director, Drug Development

Bicycle Therapeutics

Gilles Gallant

Chief Development Officer

Mythic Therapeutics

Giorgio Salciarini

Marketing & Business Development Manager

BSP Pharmaceuticals

Gordon Rigg

Principal Consultant

Apex Biologics Consulting

Greg Thurber

Associate Professor & Chair, Graduate Education

University of Michigan

Guitao Wang

President, Research & Development

Coherent Biopharma

Hans-Georg Lerchen

Chief Scientific Officer

Vincerx Pharma

Hayley Jackman

Director, CMC Regulatory Affairs

AstraZeneca

Heidi Wang

Chief Executive Officer

OBI Pharma

Hendrik Gruß

Director, Chemistry

Heidelberg Pharma

Hiroyuki Kogai

Scientist

Eisai

Irena Adkins

Director, Pharmacology

SOTIO Biotech

Jake Morris

Senior Account Manager & ADC Insights Lead

Beacon by Hanson Wade

Jake Spies

Senior Scientist, Group Lead Process & Analytical Development

Merck

Jiazhen Chen

Director, External Innovations

BioNTech

Jimmy Li

Chief Executive Officer

WuXi XDC

Jinwon Jung

Senior Director, Protein Engineering

ABL Bio

Joanna Opalinska

Senior Director of Clinical Development

GlaxoSmithKline

John Lambert

Independent Consultant & Honorary Professor

Queens University Belfast

Jon Travers

Senior Director, External Innovation & Early Development

Ipsen

Joseph Woolery

Vice President, Clinical Development

Zymeworks

Justin Mason-Home

Director

HPAPI Project Services Limited

Jutta Deckert

Vice President, Research & Development

Iksuda Therapeutics

Kati Räsänen

Independent Consultant

Kerstin Hofer

Matrix & Science Lead

Roche

Kevin Hamblett

Senior Director, ADC Biology

Pfizer

Kurt Pike

Senior Director, External Innovation

Johnson & Johnson

Lenka Sadilkova

Director, Non-Clinical Projects

Mablink Bioscience, an Eli Lilly Subsidiary

Lizzy Zhao

Senior Scientist

Regeneron

Llorente Bonaga

Senior Director, Global Regulatory Affairs & Clinical Safety, CMC

MSD

Lolke de Haan

Vice President, Toxicology

ADC Therapeutics

Lucas Donigian

Vice President, Business & Commercial Development

Zymeworks

Marcel Rieker

Principal Scientist & Team Leader PROxAb Shuttle

Merck KGaA

Maria Dahl

Chief Operating Officer & Head, Europe

Innovent Biologics

Marisa Schmitt

Director, Bioanalysis

Heidelberg Pharma

Martin Steegmaier

Chief Scientific Officer

SOTIO Biotech

Max Lee

Associate Director

AstraZeneca

Megan Rice

Senior Scientist

AstraZeneca

Meike Roskamp

Director, Bioconjugation

Daiichi Sankyo

Michael Conner

Investigator & In Vitro Scientist, Extracellular Tumour Cell Targeting Research Unit

GSK

Ming-Tain Lai

Chief Scientific Officer

OBI Pharma

Nimish Gera

Vice President, Biologics

Mythic Therapeutics

NingNing Ma

Professor

Shenyang Pharmaceutical University

Norbert Prenzel

Head, Business Development & Licensing

SOTIO Biotech

Osama Chahrour

Principal Scientist, Chemical Development

AstraZeneca

Paromita Raha

Principal Scientist

Pfizer

Paul Jaminet

Chief Executive Officer

Angiex

Paul Wolstenholme-Hogg

Vice President, Medicinal Chemistry

ADC Therapeutics

Pavan Vajjah

Executive Director, Global Head ADC Clinical Pharmacology & Safety Sciences

AstraZeneca

Radha Ramkumar

Vice President, Global Team Leader, Oncology Development

Daiichi Sankyo

Rakesh Dixit

President & Chief Executive Officer

Bionavigen Oncology

Robert Lutz

Chief Scientific Officer

Iksuda Therapeutics

Sarah-Jane Neuberth

Group Leader, In Vivo Biology

Heidelberg Pharma

Sharsti Sandall

Senior Director, Research, ADC Programs

Pfizer

Shuntaro Tsukamoto

Scientist

Eisai

Simon Chivers

Managing Director & Independent Consultant

Integrated Biologix

Tomohiro Fujii

ADC Researcher

Ajinomoto Bio-Pharma Services

Travis Biechele

Vice President, Research

Shasqi

Uchechukwu Okorji-Obike

Senior Scientist, Bioassay Development

AstraZeneca

Venkatesh Pilla Reddy

Senior Director, Global PKPD & Pharmacometrics

Eli Lilly

William Olughu

Senior Principal Scientist

Ipsen

Xiaona Jing

Senior Vice President, Global Product Development & Partnering

Multitude Therapeutics

Ying Buechler

Chief Technology Officer

Ambrx, a Johnson & Johnson Company

Yu-Shin Hsu

Research Analyst

Beacon by Hanson Wade